# NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS)

> **NCT03099694** · NA · COMPLETED · sponsor: **Xingwang Zhu** · enrollment: 340 (actual)

## Conditions studied

- Preterm Infants

## Interventions

- **PROCEDURE:** noninvasive high-frequency ventilation (nHFOV)
- **PROCEDURE:** nasal continuous positive airway pressure (nCPAP)

## Key facts

- **NCT ID:** NCT03099694
- **Lead sponsor:** Xingwang Zhu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-27
- **Primary completion:** 2018-07-28
- **Final completion:** 2018-07-28
- **Target enrollment:** 340 (ACTUAL)
- **Last updated:** 2021-03-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03099694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03099694, "NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03099694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*